An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why 50 researchers from around the world, led by Radboudumc, ...
Antifungal therapies against pathogenic yeasts exploit a handful of conserved cellular processes to disrupt fungal viability while sparing the human host. The principal targets involve the fungal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results